Zobrazeno 1 - 10
of 38
pro vyhledávání: '"Amy M. Berkman"'
Autor:
Qixin Yang, Amy M. Berkman, Jordan E. Ezekian, Michael Rosamilia, Jill A. Rosenfeld, Pengfei Liu, Andrew P. Landstrom
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 11, Iss 19 (2022)
Background As utilization of clinical exome sequencing (ES) has expanded, criteria for evaluating the diagnostic weight of incidentally identified variants are critical to guide clinicians and researchers. This is particularly important in genes asso
Externí odkaz:
https://doaj.org/article/ba7c8d8b2550418f872832ee25550ad8
Autor:
Amy M Berkman, Clark R Andersen, Michelle A T Hildebrandt, J A Livingston, Adam L Green, Vidya Puthenpura, Susan K Peterson, Joel Milam, Kimberly A Miller, David R Freyer, Michael E Roth
Publikováno v:
JNCI: Journal of the National Cancer Institute. 115:447-455
Background Advancements in treatment and supportive care have led to improved survival for adolescents and young adults (AYAs) with cancer; however, a subset of those diagnosed remain at risk for early death (within 2 months of diagnosis). Factors th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a085f4e20881b5f097e10cb8483149bd
https://doi.org/10.1093/jnci/djac206
https://doi.org/10.1093/jnci/djac206
Publikováno v:
Current Opinion in Pediatrics. 35:84-90
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::195e2a8d2ed7766a06ab589cd5f7d444
https://doi.org/10.1097/mop.0000000000001200
https://doi.org/10.1097/mop.0000000000001200
Publikováno v:
Journal of Cancer Survivorship. 17:848-858
There is a growing population of adolescent and young adult (AYA, ages 15-39 at diagnosis) cancer survivors at heightened risk of chronic conditions. Moderate to vigorous physical activity level (MVPA) is an important modifiable factor associated wit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f81f122a72a4ae2983bade96bae2c3fd
https://doi.org/10.1007/s11764-022-01264-2
https://doi.org/10.1007/s11764-022-01264-2
Autor:
Amy M. Berkman, Clark R. Andersen, Branko Cuglievan, David C. McCall, Philip J. Lupo, Susan K. Parsons, Courtney D. DiNardo, Nicholas J. Short, Nitin Jain, Tapan M. Kadia, J.A. Livingston, Michael E. Roth
Publikováno v:
Cancer Epidemiol Biomarkers Prev
Background: There is a growing population of adolescent and young adult (AYA, age 15–39 years) acute leukemia survivors in whom long-term mortality outcomes are largely unknown. Methods: The current study utilized the Surveillance, Epidemiology, an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6e3fbf2c7971b34f01aa889082567223
https://doi.org/10.1158/1055-9965.epi-21-1388
https://doi.org/10.1158/1055-9965.epi-21-1388
Excess risk of chronic health conditions in Hispanic survivors of adolescent and young adult cancers
Autor:
Amy M. Berkman, Eunju Choi, John M. Salsman, Susan K. Peterson, Christabel K. Cheung, Clark R. Andersen, Qian Lu, J. A. Livingston, Michelle A. T. Hildebrandt, Susan K. Parsons, Michael E. Roth
Publikováno v:
Journal of Cancer Survivorship.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::720efb72d313f7d8e93ed73646e728b4
https://doi.org/10.1007/s11764-023-01342-z
https://doi.org/10.1007/s11764-023-01342-z
Publikováno v:
Current opinion in pediatrics. 35(1)
There is a growing population of adolescent and young adult (AYA, ages 15-39 years) cancer patients and survivors, and the field of AYA oncology is rapidly evolving. Despite an increased focus on survival and quality of life for AYAs, gaps in knowled
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::c52a8e8346bdeeed4f3aea481184eb91
https://pubmed.ncbi.nlm.nih.gov/36592027
https://pubmed.ncbi.nlm.nih.gov/36592027
Autor:
John M. Salsman, Karly M. Murphy, Nancy Lau, Michael Roth, Susan K. Parsons, Yimin Geng, Amy M. Berkman, Elizabeth J. Siembida
Publikováno v:
Value Health
Objectives There is a paucity of research on the impact of cancer treatment on the health-related quality of life (HRQOL) of adolescent and young adult (AYA) patients with cancer. Patient-reported outcomes (PROs) are self-report measures used to asse
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5ce97a179c6b2f52b970fb8a885bd7a1
https://doi.org/10.1016/j.jval.2021.06.012
https://doi.org/10.1016/j.jval.2021.06.012
Publikováno v:
CancerREFERENCES.
There is a growing population of adolescent and young adult (AYA) cancer survivors (ages 15-39 years), and they have an elevated risk of developing cardiovascular disease (CVD). Little is known about the contribution of sociodemographic and modifiabl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0d1fa60a8058d891edc702b77ba0f370
https://pubmed.ncbi.nlm.nih.gov/36464957
https://pubmed.ncbi.nlm.nih.gov/36464957
Publikováno v:
Clin Genet
Anthracyclines, chemotherapeutic agents that have contributed to significant improvements in cancer survival, also carry risk of both acute and chronic cardiotoxicity. This has led to significantly elevated risks of cardiac morbidity and mortality am
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a8f44ad8fca8174d9f89023f23ede301
https://doi.org/10.1111/cge.13968
https://doi.org/10.1111/cge.13968